Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Which T cells cause psoriasis?

J C Prinz1

  • 1Department of Dermatology, Klinikum Innenstadt, Ludwig-Maximilians-University, Munich, Germany. joerg.prinz@irz.uni-muenchen.de

Clinical and Experimental Dermatology
|August 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Influence of Covid-19 vaccination on immune-mediated skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responses.

The British journal of dermatology·2021
Same author

[Psoriasis in dupilumab-treated atopic dermatitis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2020
Same author

[In honor of Prof. Dr. med. Dr. h.c. mult. Gerd Plewig on the occasion of his 80th birthday : Gerd Plewid-a lifetime for dermatology].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

The therapeutic potential of TNF-α antagonists in toxic epidermal necrosis: insights from two cases and adverse event reports.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.

Clinical and experimental dermatology·2026
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
See all related articles

T cells drive psoriasis vulgaris pathogenesis by contributing to skin lesions. This research explores T cell activation, receptor usage, and the role of streptococcal infections in this T-cell mediated autoimmune disorder.

Area of Science:

  • Immunology
  • Dermatology
  • Autoimmune Diseases

Background:

  • Psoriasis vulgaris is a chronic skin condition with significant T cell involvement.
  • Understanding the precise mechanisms of T cell contribution is crucial for effective treatment.

Purpose of the Study:

  • To elucidate the role of T cells in the pathogenesis of psoriasis vulgaris.
  • To investigate T cell activation and receptor usage in psoriatic lesions.
  • To explore the potential link between streptococcal infections and psoriasis.

Main Methods:

  • Review of current literature on T cell immunology in psoriasis.
  • Analysis of T cell receptor usage patterns in psoriatic skin.
  • Examination of proposed T cell activation pathways.

Related Experiment Videos

  • Integration of findings into a pathogenetic model.

    • Main Results:

    • T cells are identified as key players in the development of psoriatic skin lesions.
    • Specific T cell receptor usage suggests a targeted immune response.
    • Streptococcal throat infections are implicated as potential triggers for disease manifestations.

    Conclusions:

    • Psoriasis vulgaris is conceptualized as a T-cell mediated autoimmune disorder.
    • Further research into T cell activation and triggers like infections is warranted.
    • Targeting T cell pathways holds promise for psoriasis treatment.